Skip to main content

Advertisement

ADVERTISEMENT

News

Adjuvant Use of Derm-Maxx for DFUs

https://clinicaltrials.gov/study/NCT06455475

A 150-patient multi-center RCT will examine the effect of Derm-Maxx ADM on the healing rate of chronic DFUs unresponsive to SoC with primary outcome of the rate of wound closure at 12 weeks. The estimated study completion is Sept 2025. clinicaltrials.gov

Advertisement

Advertisement

Advertisement